Ming‐Chung Kuo

1.8k total citations
84 papers, 1.2k citations indexed

About

Ming‐Chung Kuo is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ming‐Chung Kuo has authored 84 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 31 papers in Genetics and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Ming‐Chung Kuo's work include Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (23 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Ming‐Chung Kuo is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (23 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers). Ming‐Chung Kuo collaborates with scholars based in Taiwan, United States and Japan. Ming‐Chung Kuo's co-authors include Lee‐Yung Shih, Po‐Nan Wang, Jin‐Hou Wu, Po Dunn, Tung‐Liang Lin, Chein‐Fuang Huang, Hung Chang, Tzung‐Chih Tang, Chang‐Liang Lai and Yu‐Shin Hung and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Ming‐Chung Kuo

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming‐Chung Kuo Taiwan	20	686	379	361	301	224	84	1.2k
Jin‐Hou Wu Taiwan	19	604 0.9×	351 0.9×	309 0.9×	209 0.7×	169 0.8×	59	999
Sabine Pomplun United Kingdom	15	603 0.9×	357 0.9×	274 0.8×	162 0.5×	203 0.9×	31	1.3k
Valéria Buccheri Brazil	18	471 0.7×	216 0.6×	234 0.6×	398 1.3×	204 0.9×	59	1.2k
Yeo‐Kyeoung Kim South Korea	20	675 1.0×	412 1.1×	253 0.7×	131 0.4×	261 1.2×	91	1.2k
Tung‐Liang Lin Taiwan	15	394 0.6×	214 0.6×	202 0.6×	169 0.6×	194 0.9×	33	769
R H Herzig United States	15	636 0.9×	163 0.4×	325 0.9×	217 0.7×	368 1.6×	27	1.1k
Eileen M. Boyle United States	20	592 0.9×	530 1.4×	341 0.9×	341 1.1×	444 2.0×	84	1.5k
E Jacky Switzerland	15	882 1.3×	287 0.8×	173 0.5×	156 0.5×	314 1.4×	25	1.3k
Steven Andrèsen United States	16	417 0.6×	211 0.6×	138 0.4×	205 0.7×	347 1.5×	48	915
Anand P. Jillella United States	15	485 0.7×	314 0.8×	222 0.6×	107 0.4×	280 1.3×	55	866

Countries citing papers authored by Ming‐Chung Kuo

Since Specialization

Citations

This map shows the geographic impact of Ming‐Chung Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chung Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chung Kuo more than expected).

Fields of papers citing papers by Ming‐Chung Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Chung Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chung Kuo. The network helps show where Ming‐Chung Kuo may publish in the future.

Co-authorship network of co-authors of Ming‐Chung Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Chung Kuo. A scholar is included among the top collaborators of Ming‐Chung Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Chung Kuo. Ming‐Chung Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Hung, Ming‐Chung Kuo, Jin‐Hou Wu, et al.. (2025). Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples. Cancer. 131(16). e70048–e70048.

Chuang, Wen‐Yu, Hung Chang, Lee‐Yung Shih, et al.. (2024). Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 323–334. 1 indexed citations

Kuo, Ming‐Chung, Hung Chang, Jin‐Hou Wu, et al.. (2023). Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan. Clinical and Experimental Medicine. 23(8). 5327–5336. 1 indexed citations

Chang, Hung, Che‐Wei Ou, Ming‐Chung Kuo, et al.. (2023). Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clinical and Experimental Medicine. 23(7). 3759–3766. 2 indexed citations

Liu, Hsi‐Che, Ming‐Chung Kuo, Kang‐Hsi Wu, et al.. (2023). Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan. British Journal of Cancer. 128(7). 1294–1300. 5 indexed citations

Huang, Ying‐Jung, Ming‐Chung Kuo, Tang‐Her Jaing, et al.. (2021). Comparison of Two Quantitative PCR–Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts. Journal of Molecular Diagnostics. 23(10). 1373–1379. 4 indexed citations

Chuang, Wen‐Yu, et al.. (2020). Intravascular Large B-cell lymphoma: A case series and review of literatures. Biomedical Journal. 44(4). 479–488. 16 indexed citations

Kuo, Ming‐Chung, Chien‐Feng Sun, Jin‐Hou Wu, et al.. (2017). The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis. Journal of Clinical Pathology. 71(6). 514–521. 3 indexed citations

Su, Yi‐Jiun, Ming‐Chung Kuo, Chieh‐Lin Jerry Teng, et al.. (2017). Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study. Blood. 130. 1603–1603. 1 indexed citations

10.

Chang, Hung, Ming‐Chung Kuo, Tzung‐Chih Tang, et al.. (2017). Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia. Acta Haematologica. 138(1). 10–13. 19 indexed citations

11.

Tsai, Shu‐Chun, Lee‐Yung Shih, Sung‐Tzu Liang, et al.. (2015). Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes. Clinical Cancer Research. 21(15). 3541–3551. 41 indexed citations

12.

Chuang, Wen‐Yu, Hung Chang, Lee‐Yung Shih, et al.. (2015). CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(5). 571–582. 25 indexed citations

13.

Shih, Lee‐Yung, Hung Chang, Po‐Nan Wang, et al.. (2013). Clinical Features of Testicular Lymphoma. Acta Haematologica. 131(3). 187–192. 1 indexed citations

14.

Lin, Tung‐Liang, Ming‐Chung Kuo, Lee‐Yung Shih, et al.. (2012). The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Annals of Hematology. 91(9). 1383–1391. 37 indexed citations

15.

Sanada, Masashi, Der‐Cherng Liang, Chang‐Liang Lai, et al.. (2011). A High Occurrence of Acquisition and/or Expansion of C-CBL Mutant Clones in the Progression of High-Risk Myelodysplastic Syndrome to Acute Myeloid Leukemia. Neoplasia. 13(11). 1035–IN25. 20 indexed citations

16.

Jeng, Wen‐Juei, Ming‐Chung Kuo, Lee‐Yung Shih, & Pao‐Hsien Chu. (2008). Pulmonary embolism in a patient with multiple myeloma receiving thalidomide–dexamethasone therapy. International Journal of Hematology. 87(5). 542–544. 1 indexed citations

17.

Lin, Yu‐Sheng, Pao‐Hsien Chu, Ming‐Chung Kuo, et al.. (2006). Use of a B-Type Natriuretic Peptide in Evaluating the Treatment Response of a Relapsed Lymphoma with Cardiac Involvement. International Journal of Hematology. 83(1). 44–46. 3 indexed citations

18.

Dunn, Po, Tseng‐tong Kuo, Lee‐Yung Shih, et al.. (2004). Primary Salivary Gland Lymphoma: A Clinicopathologic Study of 23 Cases in Taiwan. Acta Haematologica. 112(4). 203–208. 38 indexed citations

19.

Fang, Ji‐Tseng & Ming‐Chung Kuo. (1997). IgA Myeloma Associated with Decreased Anion Gap and Renal Failure. Renal Failure. 19(3). 481–483.

20.

Kuo, Ming‐Chung & Lee‐Yung Shih. (1995). Primary plasma cell leukemia with extensive dense osteosclerosis: complete remission following combination chemotherapy. Annals of Hematology. 71(3). 147–151. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact